RIP kinase inhibitor WEHI-345, Purity ≥98%

Synonym: 1354825-58-3; WEHI-345; N-(2-(4-Amino-3-(p-tolyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-2-methylpropyl)isonicotinamide; RIP kinase inhibitor

CAS Number: 1354825-58-3
Compound CID: 56602554

Product Size

5 mg; 10 mg; 25 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

WEHI-345 is a compound that targets RIP kinases and is a critical regulator of various cellular processes, including apoptosis, necroptosis, and inflammation.

Molecular Weight

401.46

Molecular Formula

C₂₂H₂₃N₇O

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

WEHI-345 can be employed to research the roles of RIPK1 inhibition in cellular signaling and inflammation.

Storage

Store at -20ºC.